Emerging Researchers National (ERN) Conference

nsf-logo[1]

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
    • Undergraduate Abstract Locator (2020)
    • Graduate Abstract Locator (2020)
    • Faculty Abstract Locator (2020)
  • Travel Awards
  • Resources
    • App
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • Video Contest
    • Video Contest Winners
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us

Expression of Survival Factors on BT-20 Breast Cancer Cells After Treatment with r-Moj-DN

Undergraduate #46
Discipline: Biological Sciences
Subcategory: Cell and Molecular Biology

Carolina Huertas-Ayala - University of Puerto Rico at Cayey Campus
Co-Author(s): Andrew U and Julio G. Soto, San Jose State University, San Jose, CA



Disintegrins are small peptides produced in viper venoms. Disintegrins bind to integrins and have the ability to activate signal transduction pathways that can result in apoptotic induction and survival inhibition. Cell survival is accomplished by the activation of survival factors that are needed to avoid apoptosis. Our research group has established that a recombinant mutant disintegrin, r-Moj-DN, induces apoptosis of SK-Mel-28 cell line by binding to v3 integrin and as result survival factor expression decreases. We are now investigating if different cancer cell lines expressing the same integrin receptor respond to r-Moj-DN in the same fashion. BT-20, a human breast cancer cell line, express v3 integrin. We hypothesize that the expression of survival factors will decrease after BT-20 treatment with r-Moj-DN. To test this hypothesis, BT-20 cells were treated with 2.5 μM, r-Moj-DN peptide. The expression of the survival factors was determined by extracting mRNA from the treated cells, followed by cDNA synthesis, and QPCR. We analyzed expression of the following genes: BIRC3, Survivin, and CXCL1. Our results demonstrated a decrease in expression for the three survival factor genes tested. This was also supported with fold-change down-regulation. This project will help us understand how the balance of survival factors vs. apoptotic interact depending on the treatment.

Funder Acknowledgement(s): NSF

Faculty Advisor: Julio G. Soto,

ERN Conference

The 2022 ERN Conference has been postponed.

Full Notice

What’s New

  • Congratulations to Zakiya Wilson-Kennedy on her 2021 AAAS Fellowship
  • Event Vaccination and Liability Policy
  • Webinars
  • Events|Opportunities
  • AAAS CEO Comments on Social Unrest, Racism, and Inequality
  • Maintaining Accessibility in Online Teaching During COVID-19
  • In the News
  • HBCU/CREST PI/PD Meeting

Conference Photos

ERN Conference Photo Galleries

Awards

ERN Conference Award Winners

Checking In

nsf-logo[1]

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW Washington,DC 20005
202-326-6400
Contact Us
About Us

The World's Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

 

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law
© 2022 American Association for the Advancement of Science